Business

Dassault Systemes in talks to buy drug trial software firm ArisGlobal, FT reports

Read a summary of this article on FAST.

Get bite-sized news via a new
cards interface. Give it a try.

Click here to return to FAST
Tap here to return to FAST

July 16 : French software maker Dassault Systemes is in talks to buy drug-trial software maker ArisGlobal from Nordic Capital for about $2 billion, the Financial Times reported on Thursday, citing people familiar with the matter.

• The potential deal would extend Dassault Systemes’ foray into software used in life sciences and would rank as its second-biggest acquisition after its $5.8 billion takeover of clinical trial software group Medidata Solutions in 2019, the report said.

• A transaction between the two firms is not a foregone conclusion, and talks could still fall apart, FT said.

• Reuters could not immediately verify the report.

Show More

Show Less

• In April, Dassault Systemes reported first-quarter revenue of 1.51 billion euros ($1.77 billion), in line with estimates.

• Hit by a prolonged slowdown in the global auto industry, Dassault Systemes, which provides software to automakers, plane manufacturers and industrial firms, is increasingly tapping augmented AI and data centers to drive growth.

• Dassault Systemes, ArisGlobal and Nordic Capital could not immediately be reached for comment.

Source: Reuters

Sign up for our newsletters

Get our pick of top stories and thought-provoking articles in your inbox

Get the CNA app

Stay updated with notifications for breaking news and our best stories

Get WhatsApp alerts

Join our channel for the top reads for the day on your preferred chat app

Get bite-sized news via a new
cards interface. Give it a try.

Click here to return to FAST
Tap here to return to FAST

About The Author

admin

See author's posts